FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:822-823 August 23, 2007 Number 8 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Dunckley, T. PubMed Citation

Amyotrophic lateral sclerosis (ALS) is a human disease resulting from the degeneration of motor neurons in the brain, spinal cord, and peripheral nervous system. The resultant clinical features include weakness of the arms, legs, and face and difficulties with speech, swallowing, and breathing. ALS affects women and men, regardless of ancestry, and the risk of disease increases with age. Its clinical progression is one of the fastest of the neurodegenerative diseases, with death (often from respiratory failure) typically occurring within 3 to 5 years after onset. The incidence is approximately 2 per 100,000 persons per year, and the prevalence is . . . [Full Text of this Article]

Source Information

From the University Department of Clinical Neurosciences, Institute of Neurology, University College London, London.

This article (10.1056/NEJMe078146) was published at www.nejm.org on August 1, 2007.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.